DNA methylation signature of long noncoding RNA genes during human pre-implantation embryonic development

Abstract

DNA methylation have crucial roles in regulating the expression of developmental genes during mammalian pre-implantation embryonic development (PED). However, the DNA methylation dynamic pattern of long noncoding RNA (lncRNA) genes, one type of epigenetic regulators, in human PED have not yet been demonstrated. Here, we performed a comprehensive analysis of lncRNA genes in human PED based on public reduced representation bisulphite sequencing (RRBS) data. We observed that both lncRNA and protein-coding genes complete the major demethylation wave at the 2-cell stage, whereas the promoters of lncRNA genes show higher methylation level than protein-coding genes during PED. Similar methylation distribution was observed across the transcription start sites (TSS) of lncRNA and protein-coding genes, contrary to previous observations in tissues. Besides, not only the gamete-specific differentially methylated regions (G-DMRs) but also the embryonic developmental-specific DMRs (D-DMRs) showed more paternal bias, especially in promoter regions in lncRNA genes. Moreover, coding-non-coding gene co-expression network analysis of genes containing D-DMRs suggested that lncRNA genes involved in PED are associated with gene expression regulation through several means, such as mRNA splicing, translational regulation and mRNA catabolic. This firstly provides study provides the methylation profiles of lncRNA genes in human PED and improves the understanding of lncRNA genes involvement in human PED.

LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3

“…Recent evidence demonstrates that nearly 98% of the genome transcripts in human are noncoding RNAs (ncRNA) [ 9 , 10 ], among which long noncoding RNAs (lncRNAs) are transcripts of longer than 200 nucleotides and have no protein coding potential [ 11 , 12 ]. More and more reports showed that lncRNAs have many kinds of biological functions involved in embryo development, immunoregulation, and tumor development [ 13 – 15 ]. Aberrant expression of lncRNAs is closely related with human diseases, especially in cancers [ 16 , 17 ].…”

Long Noncoding RNA CCAL Promotes Papillary Thyroid Cancer Progression by Activation of NOTCH1 Pathway

“…Many reports show that lncRNAs have no protein-coding potential 6 . Increasing evidence demonstrates that lncRNAs exerted very important functions in various biological processes, including cell development, immune regulation, and especially tumorigenesis 7–9 . More and more reports indicate that dysregulation of lncRNAs was closely related to tumor development and progression in various cancers 10,11 .…”

Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma

“…Long noncoding RNAs (lncRNA) are a class of transcripts whose length is longer than 200 nucleotides and have no protein coding potential [ 9 ]. Accumulating evidences show that noncoding RNAs (ncRNA) exert essential roles in all kinds of biological processes including development, immune and especially in tumorgenesis [ 10 – 13 ]. In cancers, lncRNAs have been demonstrated to regulate cell proliferation, migration, invasion and apoptosis by several mechanisms [ 14 ].…”